ONLINE PRESENTATION

Quantification of the Immune Response to AAV Mediated Gene Therapy

A highly sensitive iLite® reporter assay based on the establishment of a cell line stably transfected with a luciferase reporter-gene placed under the control of an AAV-responsive chimeric promoter, provides a highly sensitive, rapid and precise method for quantifying the immune response to a wide range of recombinant AAV vectors.

Watch Dr. Michael Tovey’s presentation:
"
Quantification of the Immune Response to AAV Mediated Gene Therapy"

Michael Tovey video image

Michael Tovey brings extensive knowledge and expertise in molecular genetics, signal transduction, and cell engineering and is the inventor of the iLite® reporter gene technology.

Michael is the author of more than 200 articles on cytokines, biotechnology, and immunogenicity.

 

Submit your contact details to get access to the presentation